Tactile Systems Technology, Inc. (TCMD)
24.78
+1.91
(+8.35%)
USD |
NASDAQ |
Nov 03, 16:00
24.82
+0.04
(+0.16%)
After-Hours: 20:00
Tactile Systems Technology Enterprise Value : 499.40M for Nov. 3, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 499.40M |
| November 02, 2026 | 456.44M |
| October 30, 2026 | 460.26M |
| October 29, 2026 | 488.83M |
| October 28, 2026 | 479.83M |
| October 27, 2026 | 469.71M |
| October 26, 2026 | 468.14M |
| October 23, 2026 | 473.76M |
| October 22, 2026 | 471.51M |
| October 21, 2026 | 465.66M |
| October 20, 2026 | 471.06M |
| October 19, 2026 | 453.29M |
| October 16, 2026 | 448.56M |
| October 15, 2026 | 465.89M |
| October 14, 2026 | 446.09M |
| October 13, 2026 | 443.84M |
| October 12, 2026 | 450.81M |
| October 09, 2026 | 446.76M |
| October 08, 2026 | 439.57M |
| October 07, 2026 | 437.32M |
| October 06, 2026 | 441.14M |
| October 05, 2026 | 447.44M |
| October 02, 2026 | 439.12M |
| October 01, 2026 | 430.34M |
| September 30, 2026 | 443.39M |
| Date | Value |
|---|---|
| September 29, 2026 | 455.97M |
| September 28, 2026 | 462.55M |
| September 25, 2026 | 460.51M |
| September 24, 2026 | 464.14M |
| September 23, 2026 | 453.70M |
| September 22, 2026 | 459.37M |
| September 21, 2026 | 463.23M |
| September 18, 2026 | 448.48M |
| September 17, 2026 | 456.65M |
| September 16, 2026 | 447.79M |
| September 15, 2026 | 455.51M |
| September 14, 2026 | 456.88M |
| September 11, 2026 | 453.02M |
| September 10, 2026 | 451.20M |
| September 09, 2026 | 444.39M |
| September 08, 2026 | 437.81M |
| September 04, 2026 | 440.98M |
| September 03, 2026 | 444.16M |
| September 02, 2026 | 453.24M |
| September 01, 2026 | 449.61M |
| August 31, 2026 | 466.18M |
| August 28, 2026 | 470.27M |
| August 27, 2026 | 469.13M |
| August 26, 2026 | 478.21M |
| August 25, 2026 | 479.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Treace Medical Concepts, Inc. | 306.64M |
| Abbott Laboratories | 216.96B |
| AngioDynamics, Inc. | 474.40M |
| Alphatec Holdings, Inc. | 1.684B |
| AtriCure, Inc. | 2.979B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.16M |
| Revenue (Quarterly) | 91.86M |
| Total Expenses (Quarterly) | 84.70M |
| EPS Diluted (Quarterly) | 0.3107 |
| Gross Profit Margin (Quarterly) | 76.05% |
| Profit Margin (Quarterly) | 7.79% |
| Earnings Yield | 4.16% |
| Operating Earnings Yield | 5.94% |
| Normalized Earnings Yield | 4.171 |